Avasa Secures $1.55M in Funding Round with Key Investors

AUCKLAND, New Zealand - Avasa, the pioneering medical device company based in Auckland, New Zealand, has successfully raised $1.55 million in funding. The round garnered support from prominent investors, including New Zealand Growth Capital Partners, Pacific Channel, Booster Innovation Fund, Brisbane Angels, and Cure Kids Ventures, along with continued backing from Bridgewest Group and Uniservices. Avasa, led by CEO and Founder Dr. Nandoun Abeysekera, is dedicated to revolutionizing surgical procedures with innovative implantable devices, initially focused on reconstructive microsurgery. The funding will fuel their expansion efforts and future developments in fields such as organ transplants, cardiothoracic surgery, and vascular surgery.